|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.6 NOK | -10.83% |
|
+2.19% | +15.23% |
Lytix Biopharma AS reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was NOK 1.41 million compared to NOK 0.017 million a year ago. Revenue was NOK 17.27 million compared to NOK 25.83 million a year ago.
Net loss was NOK 56.01 million compared to NOK 48.05 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +15.23% | 21.01M | |
| +33.63% | 50.93B | |
| -0.09% | 42.12B | |
| +49.62% | 42.05B | |
| -4.96% | 29.18B | |
| +11.18% | 26.02B | |
| -21.95% | 18.9B | |
| +8.61% | 13.21B | |
| +24.73% | 12.17B | |
| +28.31% | 12.16B |
LYTIX BIOPHARMA 
